ACAD
31.96
+1.59
+5.24%
AEMD
0.215
+0.005
+2.1429%
APRI
1.91
-0.01
-0.78%
ARNA
4.33
-0.01
-0.23%
ATEC
1.4
0.00
0.00%
CNAT
7.75
+0.99
+14.64%
CRXM
0.195
+0.002
+1.1837%
CYTX
1.19
+0.01
+0.85%
DXCM
60.16
+1.79
+3.07%
GNMK
13.29
+0.2
+1.53%
HALO
13.93
+0.62
+4.66%
ILMN
187.17
+2.8
+1.52%
INNV
0.13
-0.019
-12.8600%
INO
8.285
+0.195
+2.410%
ISCO
0.061
+0.003
+6.087%
ISIS
63.37
+2.22
+3.63%
LGND
72.95
+2.65
+3.77%
LPTN
2.48
-0.04
-1.59%
MBVX
1.62
-0.13
-7.43%
MEIP
1.74
-0.09
-4.92%
MNOV
3.55
+0.23
+6.93%
MRTX
28.42
+2.05
+7.77%
MSTX
0.499
-0.021
-4.038%
NBIX
38.78
+1.45
+3.88%
NUVA
44.6
+0.62
+1.41%
ONCS
0.35
+0.01
+3.40%
ONVO
3.66
-0.27
-6.87%
OREX
7.54
+0.29
+4.00%
OTIC
34.23
+0.47
+1.39%
QDEL
27.15
+0.63
+2.38%
RCPT
147.43
+8.44
+6.07%
RGLS
16.82
+0.26
+1.57%
RMD
71.55
+1.3
+1.85%
SCIE
0.031
0.00
0.00%
SPHS
0.59
+0.05
+9.2407%
SRNE
12.29
+0.44
+3.71%
TROV
7
+0.23
+3.40%
VICL
0.923
+0.068
+7.9181%
VOLC
17.99
0.00
0.00%
ZGNX
1.34
+0.03
+2.29%
ACAD
31.96
+1.59
+5.24%
AEMD
0.215
+0.005
+2.1429%
APRI
1.91
-0.01
-0.78%
ARNA
4.33
-0.01
-0.23%
ATEC
1.4
0.00
0.00%
CNAT
7.75
+0.99
+14.64%
CRXM
0.195
+0.002
+1.1837%
CYTX
1.19
+0.01
+0.85%
DXCM
60.16
+1.79
+3.07%
GNMK
13.29
+0.2
+1.53%
HALO
13.93
+0.62
+4.66%
ILMN
187.17
+2.8
+1.52%
INNV
0.13
-0.019
-12.8600%
INO
8.285
+0.195
+2.410%
ISCO
0.061
+0.003
+6.087%
ISIS
63.37
+2.22
+3.63%
LGND
72.95
+2.65
+3.77%
LPTN
2.48
-0.04
-1.59%
MBVX
1.62
-0.13
-7.43%
MEIP
1.74
-0.09
-4.92%
MNOV
3.55
+0.23
+6.93%
MRTX
28.42
+2.05
+7.77%
MSTX
0.499
-0.021
-4.038%
NBIX
38.78
+1.45
+3.88%
NUVA
44.6
+0.62
+1.41%
ONCS
0.35
+0.01
+3.40%
ONVO
3.66
-0.27
-6.87%
OREX
7.54
+0.29
+4.00%
OTIC
34.23
+0.47
+1.39%
QDEL
27.15
+0.63
+2.38%
RCPT
147.43
+8.44
+6.07%
RGLS
16.82
+0.26
+1.57%
RMD
71.55
+1.3
+1.85%
SCIE
0.031
0.00
0.00%
SPHS
0.59
+0.05
+9.2407%
SRNE
12.29
+0.44
+3.71%
TROV
7
+0.23
+3.40%
VICL
0.923
+0.068
+7.9181%
VOLC
17.99
0.00
0.00%
ZGNX
1.34
+0.03
+2.29%
Home » Events, SDBN Events

SDBN Networking Event Featuring Fate Therapeutics & Stemgent

Submitted by on July 1, 2009 – 11:41 am

The San Diego Biotechnology Network’s July 21st event will feature Fate Therapeutics and Stemgent, two companies engaged in exciting, interdisciplinary biotechnology research in San Diego that holds direct promise for making a difference in our quality of life. Ken Batchelor, Ph.D., CSO, Fate Therapeutics, and Stephen Chang, Ph.D., CSO, Stemgent will present a short talk which will be followed by networking:

CATALYST: The Industrialization of Advanced iPSC Technology for Drug Discovery & Development

For more information visit http://sdbn.org/july

Leave a comment!

Add your comment below, or trackback from your own site. You can also Comments Feed via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:

<a href="" title="" rel=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong> 

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.


9 + = fourteen